CA 27.29; BREAST CANCER MARKER

CA 27.29 is useful to monitor the response to therapy and if elevated suggests recurrence in women with Stage II or III breast Cancer.

  • Test Type:
  • Pre-test Information:
    No special preparation required
  • Report Delivery:
    Sample by 7th of the month; Report after 2–3 weeks
  • Components:
    0

Sample Report